Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial

BACKGROUND: Based on promising results from radiomic approaches to predict O(6)-methylguanine DNA methyltransferase promoter methylation status (MGMT status) and clinical outcome in patients with newly diagnosed glioblastoma, the current study aimed to evaluate radiomics in recurrent glioblastoma pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vils, Alex, Bogowicz, Marta, Tanadini-Lang, Stephanie, Vuong, Diem, Saltybaeva, Natalia, Kraft, Johannes, Wirsching, Hans-Georg, Gramatzki, Dorothee, Wick, Wolfgang, Rushing, Elisabeth, Reifenberger, Guido, Guckenberger, Matthias, Weller, Michael, Andratschke, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079773/
https://www.ncbi.nlm.nih.gov/pubmed/33937035
http://dx.doi.org/10.3389/fonc.2021.636672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079773/
https://www.ncbi.nlm.nih.gov/pubmed/33937035
http://dx.doi.org/10.3389/fonc.2021.636672

Ejemplares similares